Skip to main content
. Author manuscript; available in PMC: 2019 Apr 29.
Published in final edited form as: Lancet. 2016 Dec 1;389(10080):1756–1770. doi: 10.1016/S0140-6736(16)32126-2

Figure 4. Suggested treatment approach algorithm for mild to moderate ulcerative colitis.

Figure 4

Based on Toronto Consensus and European Crohn’s and Colitis Organisation guidelines.114,118 For patients needing and responding to steroids, the choice for maintenance medication can be either 5-ASA, thiopurine, or a biological drug. 5-ASA can be considered if partial initial response and first course of steroids. Thiopurines can be used if no response to 5-ASA, low risk of complications, and first course of steroids. Biological drugs should be used if unable to taper steroids, second course of steroids, or higher risk of complications. 5-ASA=5-aminosalicylic acid.